Free Trial

agilon health, inc. (NYSE:AGL) Shares Purchased by Price T Rowe Associates Inc. MD

agilon health logo with Medical background

Price T Rowe Associates Inc. MD boosted its position in agilon health, inc. (NYSE:AGL - Free Report) by 41.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 338,529 shares of the company's stock after acquiring an additional 98,377 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.08% of agilon health worth $644,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Barclays PLC grew its position in shares of agilon health by 21.2% during the third quarter. Barclays PLC now owns 1,228,952 shares of the company's stock worth $4,830,000 after acquiring an additional 214,830 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the period. Pines Wealth Management LLC acquired a new stake in shares of agilon health during the fourth quarter worth $51,000. Oak Thistle LLC acquired a new stake in shares of agilon health during the fourth quarter worth $25,000. Finally, Inspire Investing LLC lifted its holdings in shares of agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock worth $413,000 after purchasing an additional 112,241 shares during the period.

agilon health Stock Down 3.3%

AGL traded down $0.09 during trading hours on Friday, reaching $2.47. 2,661,743 shares of the stock traded hands, compared to its average volume of 4,894,146. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The company has a market cap of $1.02 billion, a price-to-earnings ratio of -2.62 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm's fifty day simple moving average is $4.18 and its two-hundred day simple moving average is $3.20.

agilon health (NYSE:AGL - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.04. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business's revenue was down 4.5% on a year-over-year basis. During the same period in the prior year, the business posted ($0.02) EPS. As a group, analysts forecast that agilon health, inc. will post -0.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AGL has been the subject of several recent research reports. Robert W. Baird decreased their price target on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Royal Bank of Canada lifted their price target on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. JMP Securities reissued a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Cowen reaffirmed a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Finally, TD Cowen lifted their price objective on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, agilon health currently has an average rating of "Hold" and a consensus target price of $4.90.

View Our Latest Analysis on agilon health

agilon health Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines